Long-Term Treatment With Mavacamten and Improved Left Atrial Strain in Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Lee, Hyun-Jung [1 ]
Hong, Geu-Ru [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源：
JACC-CARDIOVASCULAR IMAGING | 2025年 / 18卷 / 03期
关键词：
hypertrophic cardiomyopathy; left atrial strain; mavacamten; myocardial deformation; myosin inhibitor; MYECTOMY;
D O I：
10.1016/j.jcmg.2024.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [1] Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy
    Garcia-Pavia, Pablo
    Oreziak, Artur
    Masri, Ahmad
    Barriales-Villa, Roberto
    Abraham, Theodore P.
    Owens, Anjali T.
    Jensen, Morten K.
    Wojakowski, Wojciech
    Seidler, Tim
    Hagege, Albert
    Lakdawala, Neal K.
    Wang, Andrew
    Wheeler, Matthew T.
    Choudhury, Lubna
    Balaratnam, Ganesh
    Shah, Ashish
    Fox, Shawna
    Hegde, Sheila M.
    Olivotto, Iacopo
    EUROPEAN HEART JOURNAL, 2024,
  • [2] LONG-TERM COST EFFECTIVENESS OF MAVACAMTEN FOR TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)
    Sarker, J.
    Joshi, M.
    Wasfy, J. H.
    Beinfeld, M.
    Nhan, E.
    Whittington, M.
    Pearson, S. D.
    Rind, D. M.
    Walton, S. M.
    VALUE IN HEALTH, 2022, 25 (07) : S424 - S424
  • [3] Left atrial strain and long-term risk of atrial fibrillation in hypertrophic cardiomyopathy
    Kim, J.
    Lee, H. J.
    Kim, H. K.
    Lee, S. C.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [4] Predictors of short-term and long-term effects of mavacamten in obstructive hypertrophic cardiomyopathy
    Roehl, Kaitlin M.
    Farina, Juan Maria
    Suppah, Mustafa
    Arsanjani, Reza
    Lester, Steven J.
    Geske, Jeffrey B.
    Alsidawi, Said
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 86 : 86 - 88
  • [5] Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy
    Del Franco, Annamaria
    Palinkas, Eszter Dalma
    Bellagamba, Clarissa C. A.
    Biagioni, Giulia
    Zampieri, Mattia
    Marchi, Alberto
    Olivotto, Iacopo
    CIRCULATION-HEART FAILURE, 2024, 17 (03) : E011188
  • [6] Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
    Day, Sharlene M.
    Udelson, James E.
    Bonow, Robert O.
    JAMA CARDIOLOGY, 2023, 8 (10) : 978 - 978
  • [7] Association of left atrial strain with long-term cardiovascular mortality in hypertrophic cardiomyopathy
    Kim, J.
    Lee, H. J.
    Kim, H. K.
    Lee, S. C.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [8] Atrial Fibrillation Prevalence With Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Jaikumar, Likhitesh
    Biswas, Monodeep
    Kagan, Calvin
    Amara, Richard S.
    Reck, Kim M.
    Shorofsky, Stephen
    Dickfeld, Timm
    Wang, Libin
    See, Vincent Y.
    CIRCULATION, 2023, 148
  • [9] Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Rader, Florian
    Oreziak, Artur
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Garcia-Pavia, Pablo
    Zwas, Donna R.
    Masri, Ahmad
    Owens, Anjali
    Hegde, Sheila M.
    Seidler, Tim
    Fox, Shawna
    Balaratnam, Ganesh
    Sehnert, Amy J.
    Olivotto, Iacopo
    JACC-HEART FAILURE, 2024, 12 (01) : 164 - 177
  • [10] EFFECT OF MAVACAMTEN ON STRAIN PARAMETERS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Hilton, Thomas
    Lewontin, Myra
    Betz, Yaqub
    Higginson, Jason
    Thomas, Matthew J.
    McClean, Karen
    Perry, Allison
    Kramer, Christopher M.
    Ayers, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 757 - 757
12345